SOTORASIB, Dexamethasone 2mg Tablets, DOCETAXEL
20190009
Phase 3 small_molecule active
Quick answer
SOTORASIB, Dexamethasone 2mg Tablets, DOCETAXEL for Previously treated locally advanced and unresectable or metastatic non-small cell lung cancer (NSCLC) with KRAS p.G12C mutation is a Phase 3 program (small_molecule) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Previously treated locally advanced and unresectable or metastatic non-small cell lung cancer (NSCLC) with KRAS p.G12C mutation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active